Lilly to invest another $5.3B in Lebanon to meet demand for Mounjaro, Zepbound Inside INdiana Business
Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines | Eli Lilly and Company Investors | Eli Lilly and Company
Adult Protective Services | Department of Human Services Governor Tom Wolf
All About Speed: Lilly Drives Innovation With New Facility to Help Bring Medicines to Market BioSpace
Tirzepatide stands to reach more UK patients than semaglutide, if NICE’s rec holds FirstWord Pharma
Eli Lilly plans $4.5 billion facility in LEAP District, bringing investment to $13 billion IndyStar
Lilly plans $4.5B ‘foundry’ for advanced drug manufacturing BioPharma Dive
Eli Lilly chases $100bn weight loss drug market with $5.3bn US investment Financial Times
Eli Lilly beefs up plan to expand manufacturing in Lebanon wlfi.com
Eli Lilly Pumps $5.3B More Into Site for Making Metabolic Meds Zepbound & Mounjaro MedCity News
Eli Lilly Plans $5.3B Expansion of Pharmaceutical Manufacturing Facility in Lebanon, Indiana REBusinessOnline
Lilly announces plans to more than double size of factory in Boone County LEAP district WRTV Indianapolis
Eli Lilly Boosts Manufacturing Site With $5.3B Investment Commercial Property Executive
Lilly to pour $5B more into expanding Zepbound, Mounjaro production BioPharma Dive
Jerry Kerr, lauded Purdue civil engineering alum, dies Purdue Exponent
Eli Lilly Plans New $2.5B Manufacturing Site in Germany for Injectable Meds MedCity News